Immunotherapy Linked to Lower Relapse Risk in MOGAD
Treatment with immunotherapy is tied to a lower risk for relapse in patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD), new research shows.
United States Michael Cossoy Philippe Bilodeau Americas Committee For Treatment Research In Multiple Sclerosis University Of Manitoba
Source: medscape.com